Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.530
+0.460 (11.30%)
At close: Jul 1, 2026, 4:00 PM EDT
4.650
+0.120 (2.65%)
After-hours: Jul 1, 2026, 5:07 PM EDT
Kalaris Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $17 | Buy | Maintains | $17 | +275.28% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $14 | Buy | Maintains | $14 | +209.05% | May 13, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $26 → $25 | Buy | Maintains | $26 → $25 | +451.88% | May 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $7 | Hold | Maintains | $7 | +54.53% | Mar 31, 2026 |
| Chardan Capital | Chardan Capital | Buy Initiates $19 | Buy | Initiates | $19 | +319.43% | Dec 23, 2025 |